Alligator Bioscience AB (ATORX) - Total Liabilities

Latest as of June 2026: Skr61.79 Million SEK ≈ $6.65 Million USD

Based on the latest financial reports, Alligator Bioscience AB (ATORX) has total liabilities worth Skr61.79 Million SEK (≈ $6.65 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Alligator Bioscience AB long-term investment intensity to see how much of total assets are deployed in long-term investments.

Alligator Bioscience AB - Total Liabilities Trend (2005–2025)

This chart illustrates how Alligator Bioscience AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Alligator Bioscience AB total assets.

Alligator Bioscience AB Competitors by Total Liabilities

The table below lists competitors of Alligator Bioscience AB ranked by their total liabilities.

Company	Country	Total Liabilities
Baronsmead Second Venture Trust Plc LSE:BMD	UK	GBX1.28 Million
Tijaria Polypipes Limited NSE:TIJARIA	India	Rs821.23 Million
Oryx International Growth Fund LSE:OIG	UK	GBX4.67 Million
UIL Ltd LSE:UTL	UK	GBX66.12 Million
Westar Resources Ltd AU:WSR	Australia	AU$114.20K

Liability Composition Analysis (2005–2025)

This chart breaks down Alligator Bioscience AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Alligator Bioscience AB (ATORX) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.58	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	18.57	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.95	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alligator Bioscience AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alligator Bioscience AB (2005–2025)

The table below shows the annual total liabilities of Alligator Bioscience AB from 2005 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr103.74 Million ≈ $11.16 Million	-55.84%
2024-12-31	Skr234.93 Million ≈ $25.28 Million	+120.39%
2023-12-31	Skr106.59 Million ≈ $11.47 Million	+32.36%
2022-12-31	Skr80.53 Million ≈ $8.67 Million	+58.13%
2021-12-31	Skr50.93 Million ≈ $5.48 Million	+38.79%
2020-12-31	Skr36.69 Million ≈ $3.95 Million	-30.28%
2019-12-31	Skr52.63 Million ≈ $5.66 Million	+32.08%
2018-12-31	Skr39.85 Million ≈ $4.29 Million	+58.89%
2017-12-31	Skr25.08 Million ≈ $2.70 Million	+1.96%
2016-12-31	Skr24.59 Million ≈ $2.65 Million	+27.52%
2015-12-31	Skr19.29 Million ≈ $2.08 Million	-34.12%
2014-12-31	Skr29.27 Million ≈ $3.15 Million	+221.31%
2011-12-31	Skr9.11 Million ≈ $980.49K	+7.85%
2010-12-31	Skr8.45 Million ≈ $909.14K	+21.24%
2008-12-31	Skr6.97 Million ≈ $749.87K	+8.72%
2007-12-31	Skr6.41 Million ≈ $689.71K	+0.39%
2006-12-31	Skr6.38 Million ≈ $687.02K	-52.52%
2005-12-31	Skr13.45 Million ≈ $1.45 Million	--

About Alligator Bioscience AB

ST:ATORX Sweden Biotechnology

Market Cap

$2.29 Million

Skr21.27 Million SEK

Market Cap Rank

#29958 Global

#680 in Sweden

Share Price

Skr0.02

Change (1 day)

-2.54%

52-Week Range

Skr0.02 - Skr5.40

All Time High

Skr55.78